Mrs. Patel should avoid Irbesartan during her pregnancy, as it is known to cause significant risks to fetal development. Hydrochlorothiazide is generally considered safer, while Methyldopa is often prescribed to manage hypertension in pregnant women. Nadolol can be used with caution, but its safety is less certain. ;
Mrs. Patel should avoid Irbesartan during her pregnancy due to its potential risks to fetal development. Hydrochlorothiazide and Methyldopa are generally considered safer, while Nadolol should be used cautiously. In conclusion, Irbesartan is the medication that poses the greatest risk and should be avoided.
;